CPD Courses

NICE type 2 diabetes guideline – what’s changed?

Training Video AstraZeneca

About the CPD course

The latest update to the NICE guideline (NG28) has seen a paradigm shift in the treatment of type 2 diabetes (T2D) and how it is managed; with the updated guideline recognising cardiovascular risk management as equally important as blood glucose control. This ~7-minute video will look in more detail at: The key treatment recommendations in the updated guideline. How to translate the update guideline into the daily management of your T2D patients within Primary Care.

CPD Provider

AstraZeneca

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.

More CPD courses by AstraZeneca

Healthcare & Medical

Cardiorenal protection: a risk-based approach to m...

AstraZeneca

An interactive and engaging presentation developed for UK based GPs; practice based and primary care...
Literature
Healthcare & Medical

Simplifying the management of heart failure across...

AstraZeneca

A thorough presentation developed for UK based cardiologists and cardiology-specialist nurses; highl...
Seminar
Healthcare & Medical

Are you confident taking a risk-based approach in...

AstraZeneca

An update to the NICE type 2 diabetes guidelines (NG28) has seen a paradigm shift in how type 2 diab...
Online Course
Healthcare & Medical

Are you considering cardiovascular risk in type 2...

AstraZeneca

The treatment of type 2 diabetes (T2D) has evolved from blood glucose control being recognised as th...
Training Video

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy